Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.

Phase 3

Novartis